REG - IP Group PLC - Directorate change

IPAnnouncement

14/01/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260114:nRSN7808Oa&default-theme=true

RNS Number : 7808O  IP Group PLC  14 January 2026

 FOR RELEASE ON  14 January 2026

Board change

IP Group plc (LSE: IPO) ("the Group"), which invests in breakthrough science
and technology companies with the potential to create a better future for all,
announces that, in accordance with UK Listing Rule 6.4.9(2), it has received
notification from Sir Douglas Flint, CBE, Chair of IP Group, that he will join
the Board of Prudential plc as independent non-executive director, and Chair
designate, with effect from March 2026.

As a result, Sir Douglas Flint has confirmed his intention to retire as a
Director and Chair of IP Group at the conclusion of the Group's Annual General
Meeting in June 2026 and will therefore not stand for re-election.

As outlined in the Notice of the 2025 AGM, the Board's Nomination Committee
has been planning succession to ensure a suitable sequencing of transition
given that a number of directors, including the Chair, are approaching the
nine year maximum term and has been prioritising the Chair succession as part
of this. This process is ongoing and the Group will provide a further update
in due course.

For more information, please contact:

 

 IP Group plc                       www.ipgroupplc.com
 Liz Vaughan-Adams, Communications  +44 (0) 20 7444 0062/+44 (0) 7967 312125
 Portland
 Lewis Bendall-Craft                +44 (0) 7931 973950

 

Notes for editors

 

About IP Group

 

IP Group accelerates the impact of science for a better future. As the most
active UK based, early stage science and technology investor, we develop and
support some of the world's most exciting businesses in healthtech, deeptech
and cleantech. Through Parkwalk, the UK's largest growth EIS fund manager, we
also back world-changing innovation emerging in leading universities and
research institutions. Our specialist investment team combines sector
expertise with an international approach. Together we have a strong track
record of success, having backed high-profile companies including Oxford
Nanopore Technologies plc, Hinge Health, Featurespace, First Light Fusion,
Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock
Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com
(http://www.ipgroupplc.com/) .

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOABJMJTMTBBTAF



            Copyright 2019 Regulatory News Service, all rights reserved